← FDA Drug Approvals (Drugs@FDA)

ZOLEDRONIC ACID

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS · Approved 2017-12-29

Drug application

FDA Application #

ANDA207341

Application type

Abbreviated New Drug Application (Generic)

Brand name

ZOLEDRONIC ACID

Generic name

ZOLEDRONIC ACID

Active ingredients

ZOLEDRONIC ACID

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BPI LABS

Manufacturer

BPI Labs LLC

First approval

2017-12-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown